Nabriva Therapeutics plc Quarterly Quick Ratio in % from Q2 2020 to Q1 2023

Taxonomy & unit
ratio: %
Description
The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary
Nabriva Therapeutics plc quarterly Quick Ratio history and growth rate from Q2 2020 to Q1 2023.
  • Nabriva Therapeutics plc Quick Ratio for the quarter ending March 31, 2023 was 53.4 %, a 25.8% decline year-over-year.
Quick Ratio, Quarterly (%)
Quick Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2023 53.4 -18.6 -25.8% Mar 31, 2023
Q4 2022 68.6 +6.77 +11% Dec 31, 2022
Q3 2022 79.2 +25.7 +48.1% Sep 30, 2022
Q2 2022 78.9 +33 +72.1% Jun 30, 2022
Q1 2022 72 +28.1 +64.1% Mar 31, 2022
Q4 2021 61.8 +21.7 +54% Dec 31, 2021
Q3 2021 53.5 +22 +70% Sep 30, 2021
Q2 2021 45.8 +27 +143% Jun 30, 2021
Q1 2021 43.9 Mar 31, 2021
Q4 2020 40.1 Dec 31, 2020
Q3 2020 31.5 Sep 30, 2020
Q2 2020 18.8 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.